<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2192">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365764</url>
  </required_header>
  <id_info>
    <org_study_id>CIC1421-20-06</org_study_id>
    <nct_id>NCT04365764</nct_id>
  </id_info>
  <brief_title>Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study</brief_title>
  <official_title>Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Intercommunal Robert Ballanger</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Intercommunal Montfermeil-Le Raincy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Hospitalier Pitie-Salpetriere</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several treatments have been used in during the Covid-19 pandemic of 2020. Using patients'
      registries from several hospitals in Paris, the investigators retrospectively analyzed
      associations between specific treatments, including but not limited to hydroxychloroquine,
      azithromycin, remdesivir, baricitinib, tocilizumab, sarilumab, lopinavir/ritonavir and
      oseltamivir; and clinical outcomes including, death and mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several treatments have been used in during the Covid-19 pandemic of 2020. Using patients'
      registries from several hospitals in Paris, the investigators retrospectively analyzed
      associations between specific treatments, including but not limited to hydroxychloroquine,
      azithromycin, remdesivir, baricitinib, tocilizumab, sarilumab, lopinavir/ritonavir and
      oseltamivir; and clinical outcomes including, death and mechanical ventilation.

      Other outcomes of interest include: acute kidney injury, encephalopathy, need for intensive
      care unit transfers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of death and mechanical ventilation</measure>
    <time_frame>14-days follow-up</time_frame>
    <description>Composite of death and mechanical ventilation (i.e. intubation)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>14-days follow-up</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation</measure>
    <time_frame>14-days follow-up</time_frame>
    <description>Enabled by intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of death and mechanical ventilation</measure>
    <time_frame>28-days follow-up</time_frame>
    <description>Composite of death and mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>World Health Organization score</measure>
    <time_frame>14-days follow-up</time_frame>
    <description>World Health Organization score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>World Health Organization score</measure>
    <time_frame>28-days follow-up</time_frame>
    <description>World Health Organization score</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Covid-19</condition>
  <condition>ARDS</condition>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>Exposed to the treatment</arm_group_label>
    <description>Exposure variable will be studied treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not exposer to the treatment (control group)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is cohort-base in routine care, in medical departments.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted for severe Covid-19 pneumonia (i.e. requiring O2-support more than 6L/min
             with SpO2&lt;96%)

        Exclusion Criteria:

          -  patients who were previously in ICU

          -  patients already hospitalized prior to study start date

          -  patients in palliative care

          -  lack of consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joe-Elie Salem, MD, PhD</last_name>
    <phone>01 42 16 00 00</phone>
    <phone_ext>+33</phone_ext>
    <email>joe-elie.salem@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Robert Ballanger</name>
      <address>
        <city>Aulnay-sous-Bois</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène Gros, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Le Raincy-Montfermeil</name>
      <address>
        <city>Montfermeil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anis Saib, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Hospitalier Pitie-Salpetriere</investigator_affiliation>
    <investigator_full_name>Lee S Nguyen</investigator_full_name>
    <investigator_title>Study coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD may be available on request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

